Henderson John T. - 11 Dec 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
/s/ Robert Wong, attorney-in-fact for Dr. Henderson
Issuer symbol
CYTK
Transactions as of
11 Dec 2024
Net transactions value
-$2,251
Form type
4
Filing time
12 Dec 2024, 16:05:54 UTC
Previous filing
03 Oct 2024
Next filing
06 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $13,119 +1,780 +4.6% $7.37 40,241 11 Dec 2024 Direct
transaction CYTK Common Stock Sale $89,748 -1,780 -4.4% $50.42 38,461 11 Dec 2024 Direct
transaction CYTK Common Stock Options Exercise $74,378 +10,092 +26% $7.37 48,553 11 Dec 2024 Direct
holding CYTK Common Stock 83 11 Dec 2024 by Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -1,780 -15% $0.000000 10,092 11 Dec 2024 Common Stock 1,780 $7.37 Direct
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -10,092 -100% $0.000000 0 11 Dec 2024 Common Stock 10,092 $7.37 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).